ContentsUse this page to navigate through the magazine.P3: Editor's NoteP4: Subscribe to the Xtalks Clinical Edge Digital MagazineP5: Gene Therapy Innovation for Rare Neurological Disorders at NovartisP6: Targeting CNS Cancers with Precision Radiotherapeutics at Plus TherapeuticsP7: Xtalks Resources for Life Science ProfessionalsP8: Targeting MASH and Obesity Through Mitochondrial Science at Rivus PharmaceuticalsP9. Boost Brand Recognition in Pharma/BiotechP10: How Jasper Therapeutics Is Rethinking Trial Design with Translational Models and Digital ToolsP11. Xtalks Life Science PodcastP12: Amgen’s Innovation Strategy for Rare and Ultra-Rare Disease PatientsP13. Xtalks Job Search for Life Science Career OpportunitiesP14: RadioMedix on Radiopharmaceuticals and the Future of Cancer CareP15. Diakonos Oncology’s Innovation in Dendritic Cell Therapy for Hard-to-Treat CancersP16: Xtalks Open MicP17. How Ardelyx Embeds the Patient's Voice in Drug DevelopmentP18. How DiMe Aims to Build Truly Digital Clinical TrialsP19. Xtalks Featured Community MembersP20. What’s Next in Clinical Innovation for Asthma Care at AstraZenecaP21. A Blueprint for Commercializing Gene Therapy in Rare DiseaseP22: Vera Therapeutics on Redefining Autoimmune Kidney Disease TreatmentP23: Contact UsCover PageEditor's Note